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Cyclin B1-Cdk1 facilitates MAD1 release from the
nuclear pore to ensure a robust spindle checkpoint
Mark Jackman*, Chiara Marcozzi*, Martina Barbiero, Mercedes Pardo, Lu Yu, Adam L. Tyson, Jyoti S. Choudhary, and Jonathon Pines
How the cell rapidly and completely reorganizes its architecture when it divides is a problem that has fascinated researchers
for almost 150 yr. We now know that the core regulatory machinery is highly conserved in eukaryotes, but how these multiple
protein kinases, protein phosphatases, and ubiquitin ligases are coordinated in space and time to remodel the cell in a matter
of minutes remains a major question. Cyclin B1-Cdk is the primary kinase that drives mitotic remodeling; here we show that it
is targeted to the nuclear pore complex (NPC) by binding an acidic face of the kinetochore checkpoint protein, MAD1, where it
coordinates NPC disassembly with kinetochore assembly. Localized cyclin B1-Cdk1 is needed for the proper release of MAD1
from the embrace of TPR at the nuclear pore so that it can be recruited to kinetochores before nuclear envelope breakdown to
maintain genomic stability.
Introduction
The rapid and complete reorganization of a cell at mitosis is one
of the most striking events in cell biology, but we are only just
beginning to understand how it is achieved. To understand the
remarkable coordination required to remodel the interphase cell
into a mitotic cell that is specialized to separate the genome
equally into two daughter cells, we must elucidate the mecha-
nisms by which the mitotic regulators disassemble interphase
structures and promote the assembly of the mitotic apparatus.
The conservation of much of the machinery through evolution
has allowed us to establish that coordinated efforts of multiple
protein kinases and phosphatases are required to remodel the
cell. Chief among these are the activation of Cyclin B1-Cdk1, the
major mitotic kinase in almost all organisms studied to date, and
the concomitant inhibition of its antagonistic PP2A-B55δ phos-
phatase (Castilho et al., 2009; Gharbi-Ayachi et al., 2010;
Mochida et al., 2010). Together, these drive the cell to enter
mitosis. As the level of cyclin B1-Cdk1 activity rises in the cell, it
triggers different events at different times (Gavet and Pines,
2010). But how this is achieved, and how the disassembly of
interphase structures contributes to the assembly of mitosis-
specific structures, are still largely unknown.
Although cyclin B1-Cdk1 was identified as the major mitotic
kinase in the 1980s (Arion et al., 1988; Dore´e and Hunt, 2002;
Dunphy and Newport, 1989; Labbe et al., 1988; Meijer et al., 1989;
Minshull et al., 1989), and a plethora of crucial substrates have
been identified since then (Nigg, 1995; Wieser and Pines, 2015),
it is remarkable that we still do not understand how cyclin B1-
Cdk1 recognizes its substrates. Our knowledge is limited to the
minimal consensus sequence recognized by Cdk1 (S/T-P, opti-
mally in the context of basic residues; De Bondt et al., 1993;
Jeffrey et al., 1995; Brown et al., 1999; Alexander et al., 2011), and
evidence that its associated Cks subunit, which also binds to
Cdk2, preferentially recognizes phospho-threonines in a (F/I/L/
P/V/W/Y-X-pT-P) consensus (McGrath et al., 2013). By contrast,
we know that the major interphase cyclin-Cdk complexes, cy-
clins A and E, recognize many substrates through the Cy motif
(RxL), which binds to the “hydrophobic patch” on the first cyclin
fold (Schulman et al., 1998; Brown et al., 1999, 2007), and the
D-type cyclins have a LxCxE motif that recognizes the retino-
blastoma protein (Dowdy et al., 1993).
Elucidating how cyclin B1-Cdk1 activity is directed to the
right substrate at the right time as cells enter mitosis is essential
to understand how cells are remodeled because cyclin B1-Cdk is
both the essential trigger and the “workhorse” of mitosis. Evi-
dence for its role as the trigger of mitosis is that mouse embryos
with a genetic deletion of cyclin B1 (Brandeis et al., 1998) stop
dividing around the four-cell stage as soon as the maternal stock
of cyclin B1 is degraded (Strauss et al., 2018); these cells arrest in
G2 phase and are unable to initiate mitosis (Strauss et al., 2018).
To ensure that cells remain in mitosis, cyclin B1-Cdk1 phos-
phorylates and activates the Greatwall protein kinase, which
generates an inhibitor of the PP2A-B55 phosphatase that an-
tagonizes cyclin B1-Cdk1 in interphase (Castilho et al., 2009;
Gharbi-Ayachi et al., 2010;Mochida et al., 2010). In its role as the
workhorse of mitosis (Nigg, 1995), cyclin B1-Cdk1 phosphor-
ylates structural components throughout the cell including the
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nuclear lamins (Heald and McKeon, 1990; Peter et al., 1990),
nuclear pore components (Linder et al., 2017), condensins
(Hirano, 2012), and cytoskeletal regulators such as the Rho
Guanine nucleotide exchange factor ECT2 (Tatsumoto et al.,
1999). Microtubule motors, nonmotor microtubule-associated
proteins, endoplasmic reticulum, and Golgi apparatus compo-
nents are also extensively phosphorylated by cyclin B1-Cdk1
(Champion et al., 2017; Wieser and Pines, 2015). A crucial role
for cyclin B1-Cdk1 is to activate the anaphase promoting com-
plex/cyclosome (APC/C), the ubiquitin ligase that will subse-
quently degrade cyclin B1itself (Fujimitsu et al., 2016; Golan
et al., 2002; Lu et al., 2014; Passmore et al., 2005; Qiao et al.,
2016). But cyclin B1-Cdk is also required for the spindle assembly
checkpoint (SAC; D’Angiolella et al., 2003; Morin et al., 2012;
Va´zquez-Novelle et al., 2014; Wieser and Pines, 2015; Hayward
et al., 2019) that keeps the APC/C from degrading cyclin B1 (and
the separase inhibitor, securin) until all the kinetochores are
attached to the mitotic spindle, which is essential for genomic
stability (Lara-Gonzalez et al., 2012; Musacchio and Salmon,
2007).
One insight into how one kinase can coordinate so many
different events is that cyclin B1-Cdk1 is targeted to different
structures as the cell enters mitosis. Human cyclin B1-Cdk is
activated on centrosomes (Jackman et al., 2003), and a large
fraction immediately moves into the nucleus over ∼20 min
preceding the breakdown of the nuclear envelope (NEBD; Gavet
and Pines, 2010; Hagting et al., 1999; Pines and Hunter, 1991).
Subsequently, cyclin B1-Cdk binds to the microtubules around
the spindle caps, to chromosomes in early mitosis, and to un-
attached kinetochores (Bentley et al., 2007; Chen et al., 2008;
Pines and Hunter, 1991). These observations indicate that the
localization of cyclin B1-Cdk1 may be an important determinant
of how specific substrates are recognized at specific times.
The remodeling of the cell at mitosis raises another important
question: when interphase macromolecular machines are dis-
assembled in mitosis, do their components, or subcomplexes of
their components, contribute to the function of newly assembled
mitotic machines? For example, there is an intriguing connec-
tion between the NPC and kinetochores because when the NPC
is disassembled at the end of prophase, several NPC components
relocalize to kinetochores in mitosis, including the Nup107-160
complex (Loı¨odice et al., 2004; Zuccolo et al., 2007), Nup358/
RanBP2, and Crm1 (Dasso, 2006; Joseph et al., 2004; reviewed in
Forbes et al., 2015). Moreover, the MAD1 and MAD2 SAC pro-
teins are prominently bound to the NPC in interphase (Chen
et al., 1998; Lee et al., 2008); in mitosis, these bind to unat-
tached kinetochores to generate the mitotic checkpoint complex
(MCC, composed of MAD2, BubR1, Bub3, and Cdc20) that in-
hibits the APC/C to prevent premature sister chromatid sepa-
ration and aneuploidy (London and Biggins, 2014; Moyle et al.,
2014; Sudakin et al., 2001; Izawa and Pines, 2015).
In budding yeast, which maintain a nuclear envelope during
mitosis, MAD1 modulates nuclear transport in response to ki-
netochore detachment from microtubules (Cairo et al., 2013),
but it is unclear whether MAD1 and MAD2 have an interphase
role at the NPC in cells that break down their nuclear envelope
in mitosis. Rodriguez-Bravo et al. (2014) have proposed that in
interphase, the MAD1/MAD2 heterodimer at the nuclear pore in
human cells can catalyze the production of the MCC before ki-
netochores are assembled from late G2 into mitosis (Gascoigne
and Cheeseman, 2013), and that this is required to generate
sufficient MCC in interphase and inhibit the APC/C when it is
fully activated at NEBD (Rodriguez-Bravo et al., 2014). The im-
portance of this is uncertain, however, since there are several
other mechanisms that keep the APC/C in check in interphase:
the Emi1 inhibitor and cyclin A-Cdk complexes both inhibit the
Cdh1 coactivator (Reimann et al., 2001; Sørensen et al., 2001; Di
Fiore and Pines, 2007; Frye et al., 2013), and phosphorylation by
cyclin A-Cdk complexes prevents the Cdc20 coactivator from
binding the APC/C (Hein and Nilsson, 2016; Labit et al., 2012).
Moreover, Cdc20 cannot bind to the APC/C until an auto-
inhibitory loop of the APC1 subunit is phosphorylated by
cyclin-Cdk and Plk1 kinases at mitosis (Qiao et al., 2016; Zhang
et al., 2016). A recent report has proposed a further “timer”
mechanism that is activated after NEBD, whereby phosphoryl-
ation of the Bub1 protein by Cdk1 and the MPS1 kinase recruits
MAD1 to kinetochores to generate the MCC independently of the
pathway that responds to microtubule attachment (Qian et al.,
2017). Thus, the means by which the cell ensures that newly
activated mitotic APC/C is kept inhibited until all kinetochores
attach to microtubules is a matter of some debate.
Here we uncover a connection between disassembly of the
NPC and the generation of a kinetochore competent for SAC
signaling that depends on the targeting of cyclin B1 toMAD1. We
show that the MAD1 protein binds to cyclin B1 through an acidic
patch in a predicted helical domain of MAD1, and that binding is
required to recruit cyclin B1 to unattached kinetochores. We
further show that cyclin B1 binding toMAD1 is important for the
proper release of MAD1 from the nuclear pore and its timely
recruitment to kinetochores before NEBD, and thus for the
ability of kinetochores to generate a robust SAC signal in early
mitosis. Our findings provide evidence for the importance of
localized cyclin B1-Cdk1 activity in the coordinated reorganiza-
tion of the cell as it enters mitosis. We also provide a mechanism
for how the cell coordinates activation of the APC/C with the
generation of the MCC to keep the APC/C in check in early
mitosis and consequently contribute toward genomic stability.
Results
Cyclin B1 binds to MAD1 through the acidic face of a helix
encoded by exon 4
We sought to understand what controls the highly dynamic
behavior of cyclin B1-Cdk1 complexes as the cell enters mitosis;
in particular, how cyclin B1 is recruited to specific places in the
cell at specific times. To identify binding partners, we im-
munoprecipitated cyclin B1 from both normal diploid retinal
pigment epithelial (RPE) cells and from transformed HeLa cells
and analyzed the coprecipitating proteins by mass spectrometry
(Table 1 and data submitted to the Proteomics Identification
Database (PRIDE) database, PXD017202). We foundMAD1 as one
of the most prominent proteins in immunoprecipitates from
both cell lines. We confirmedMAD1 as a major cyclin B1–binding
partner by immunoblotting. It coimmunoprecipitated with
Jackman et al. Journal of Cell Biology 2 of 17
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cyclin B1 from cells in both G2 phase and mitosis (Fig. 1 A; see
also Fig. S1), but we noticed that there were two isoforms of
MAD1 detected by immunoblotting HeLa cell lysates, of which
only the more slowly migrating form (MAD1α) coimmunopre-
cipitated with cyclin B1 (Fig. 1 A). A previous study had identi-
fied an alternatively spliced form of MAD1 (MAD1β) in
hepatocellular carcinoma cells (Sze et al., 2008), which lacks the
47 amino acid–encoding exon 4 of MAD1α and migrates at the
same molecular mass as our faster migrating form of MAD1.
Therefore, we expressed MAD1α and MAD1β from cDNAs and
found that only MAD1α bound to cyclin B1 (Fig. S1 C). In
agreement with this, expressing a series of truncation mutants
showed that residues 39–329 were able to bind to cyclin B1 (data
not shown).
These analyses implicated the peptide sequence encoded by
exon 4 (residues 51–97) as important for binding to cyclin B1;
however, exon 4 also contains the nuclear localization sequence
(79KKR82) of MAD1, previously shown to be important for its
function and its proper localization to the NPC in interphase
(Sze et al., 2008). Therefore, we sought to narrow down the
residues required to interact with cyclin B1. A region of the
RepoMan protein between amino acids 403–550 had been re-
ported to bind cyclin B1 (Qian et al., 2015); when we compared
this region to exon 4 of MAD1, we found a five amino acid region
of homology (L51-E56aa of MAD1, Fig. 1 B). This region of MAD1
is predicted to be part of helical region by JPred (Cole et al.,
2008), and likely to form a coiled-coil. Mutating all five resi-
dues (L51G/E52A/E53A/R54A/E56A) disrupted the ability of
MAD1 to bind to the nuclear envelope (Fig. S1, D and E), likely
due to altering the ability of MAD1 to form a coiled-coil structure
at this position; therefore, we sought a more refined mutation
that still maintained the hydrophobic (L51, A55) and charged
(E52, R54) residues predicted to stabilize the coiled-coil struc-
ture. We identified two acidic residues within this region, E53
and E56, that should be exposed to the outside face of the pre-
dicted coiled-coil (Fig. S1 D). An interaction with an acidic sur-
face could conceivably be used to confer specificity for binding
to B-type cyclins in animal cells because comparing the struc-
tures of B- and A-type cyclins shows that B-type cyclins are
distinguished by their conserved basic patches at their interface
with Cdk2 (Brown et al., 2007). When we made the double
charge substitution of E53/56K, we found this severely per-
turbed binding of MAD1 to cyclin B1 in vitro (Fig. 1, C and D) but
not localization of full length MAD1 to the nuclear envelope in
interphase (Fig. S1 E), nor binding to MAD2 (see below).
MAD1 recruits cyclin B1 to kinetochores
We sought to identify the function of the binding betweenMAD1
and cyclin B1. We used CRISPR/Cas9D10A (Fig. S2 A) to introduce
the E53/56K mutation into both alleles of MAD1 in RPE1 cells in
which we had tagged one allele of cyclin B1 with the Venus
yellow fluorescent protein, and one allele of MAD2 with the
Ruby red fluorescent protein. We isolated single cell clones of
the parental and mutant cells and confirmed the MAD1 point
mutations in two independent clones (7D2 and 8B12) by PCR
analysis and genome sequencing (Fig. S2 B). In agreement with
our in vitro analysis, the MAD1 E53/56Kmutants were unable to
bind cyclin B1 (Fig. 2 A and Table 1), but were still able to bind to
MAD2 (Fig. 2 B), as expected, because MAD2 binds to a region of
MAD1 450 amino acids away. Mutating MAD1 in the RPE1 cyclin
B1-Venus:Ruby-MAD2 cells allowed us to assay cyclin B1 and
MAD2 recruitment to kinetochores in living cells. This showed
that in both clones, the E53/56K mutation prevented cyclin B1
but not MAD2 from being recruited to unattached kinetochores
in prometaphase cells (Fig. 2 C and Video 1, Video 2, and Video
3). We were thus in a position to determine the role of MAD1
binding to cyclin B1 and recruiting it to kinetochores.
MAD1 binding to cyclin B1 is required for genomic stability
We first analyzed the chromosomal stability of our MAD1 E53/
56K clones compared with the parental RPE1 cells by counting
the chromosome number in metaphase spreads. This showed
that mutating MAD1 dramatically increased chromosomal in-
stability: more than 85% of cells in both mutant clones had
gained or predominantly lost chromosomes, compared with 24%
of the parental (Fig. 3 A). The increase in chromosomal insta-
bility in the MAD1 E53/56K clones might be explained by a
weaker SAC. To test this, we assayed the SAC under three
conditions: untreated cells, where the time from NEBD to ana-
phase is determined by the SAC (Fig. 3 B); mitotic delay in cells
treated with low doses of nocodazole (Fig. 3 C); and mitotic delay
in cells treated with paclitaxel (Fig. S3). There was no significant
difference in timing between the wild-type andmutant clones in
untreated cells, but neither MAD1 mutant clone was able to ar-
rest for as long as the parental cells in response to nocodazole or
paclitaxel. Thus, we conclude that MAD1 recruitment of cyclin
Table 1. Relevant proteins significantly enriched after CCNB1 immunoprecipitation and quantitative mass spectrometry analysis
Mean abundance FC (Adjusted P value)
Accession no.: Description IgG CCNB1 CCNB1 CCNB1 CCNB1 CCNB1 CCNB1
WT D2 B12 WT/IgG WT/D2 WT/B12
P14635 Cyclin B1 737.6 60,035.3 45,962.5 54,126.8 6.60 (1.61 e-07) −0.54 (0.96) −0.03 (0.99)
Q9Y6D9 MAD1 1,170.7 50,184.2 1,280.1 3,631.2 5.47 (2.39 e-06) −5.25 (3.06 e-05) −3.54 (0.016)
Q15013 MAD2 66.1 2,914.0 60.9 233.5 5.68 (1.02 e-05) −5.61 (5.66e-05) −3.83 (0.019)
Mean abundance is the average abundance from three biologically independent experiments, and FC is the fold change. Significantly enriched proteins were
identified by LIMMA test (P < 0.05).
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B1 to kinetochores strengthens the SAC and that this contributes
to long-term genomic stability.
Cells with MAD1 mutants that cannot bind cyclin B1 are
sensitive to partial inhibition of MPS1
In our previous studies on the strength of SAC signaling, we
showed that there was an inverse correlation between the
strength of the SAC and the dose of an MPS1 inhibitor (Collin
et al., 2013). We reasoned that partial inhibition of MPS1 might
sensitize cells and uncover a more penetrant role for cyclin B1-
Cdk1 binding to MAD1. In agreement with this, when we treated
cells with low doses of an MPS1 inhibitor, either reversine
(Fig. 4) or AZ3146 (Fig. S4), we found that the SAC was much
more severely compromised in the MAD1 E53/56K mutant
Figure 1. MAD1 binds to cyclin B1 through the acidic face of a helix within exon 4. (A) HeLa cells were synchronized in either G2 phase or mitosis (M),
cyclin B1 and MAD1 were immunoprecipitated (IP), subjected to SDS-PAGE and immunoblotted with anti-MAD1 (upper panel), and anti-cyclin B1 antibodies
(lower panel). The difference in stoichiometries of binding is likely to be related to epitope accessibility, but we note that Schweizer et al. (2013) previously identified
cyclin B1 in MAD1 immunoprecipitates. Schematic shows the location of exon 4 in MAD1α that is absent from MAD1β. (B) Similarity between MAD1 and Repoman
sequences within the regions found to interact with cyclin B1. (C) HeLa cells expressing wild-type or mutated MAD1-Flag (39-329aa) from a tetracycline-inducible
promoter (tet ON) were synchronized in either G2 phase or mitosis 12 h after adding tetracycline. Cyclin B1 was immunoprecipitated, subjected to SDS-PAGE, blotted
with anti-FLAG antibody, and assayed on a LiCOR Odyssey scanner. (D) The data from three experimental repeats were normalized to the amount of cyclin B1
binding to wild-type MAD1 and plotted using Prism software. Error bars represent SD; two-tailed P values were calculated using an unpaired t test.
Jackman et al. Journal of Cell Biology 4 of 17
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clones than in the parental clones, as assayed by both the timing
fromNEBD to anaphase in the absence of a spindle poison (Fig. 4
A) and by the ability of cells to arrest in nocodazole (Fig. 4 B).
Furthermore, live-cell analyses of chromosome behavior in
these cells revealed that around 80% of the MAD1 mutant cells
failed to form a propermetaphase plate and performed anaphase
with a large number of lagging chromosomes, compared with
<20% of the parental cells (Fig. 4 C; and see Videos 4, 5, 6, and 7).
The premature sister chromatid separation exhibited by the
MAD1 mutant cells could have one of two explanations: either
they were unable to activate the SAC, or they were unable to
maintain the SAC while the number of signaling kinetochores
diminished following microtubule attachment. To distinguish
between these two possibilities, we analyzed the kinetics of
cyclin B1-Venus degradation (Fig. 4 D). In parental cells, cyclin
B1-Venus was stable until the SACwas inactivated inmetaphase,
but in both MAD1 mutants, it was only stable for a few minutes
after NEBD and was then degraded at a similar rate to wild-type
cells that have satisfied the SAC. This showed that the SAC was
initially active in the mutant cells but could not be maintained
(Fig. 4 D). Thus, we conclude that the SAC is much more de-
pendent onMPS1 kinase activity whenMAD1 is unable to recruit
cyclin B1.
MAD2 recruitment to kinetochores is delayed when MAD1
cannot bind cyclin B1
To gain insight into the mechanism underlying the weaker SAC
signaling and the greater dependence on MPS1 in cells where
MAD1 cannot bind cyclin B1, we studied the recruitment of SAC
proteins to kinetochores as cells began mitosis. To do this, we
used CRISPR/Cas9D10A to introduce an RFP670 fluorescent tag
into the MIS12 protein (Fig. S5, A–C; see also Videos 6 and 7) so
that we could identify kinetochores in living cells. We then as-
sayed the recruitment of MAD2 to kinetochores by quantifying
the colocalization between MAD2 and MIS12 (see Materials and
methods). This showed a striking difference between the pa-
rental and MAD1 E53/56K mutant clones (Fig. 5, A and B). In
parental cells, MAD2 began to be recruited to the newly formed
kinetochores 10min or more before NEBD, whereas recruitment
was markedly delayed in the MAD1 mutant cells; indeed, in the
cells of one clone (7D2), MAD2 was not recruited until NEBD. In
cells of the other clone (8B12), MAD2 recruitment was also much
slower than normal, and never reached the amounts seen in
parental cells (Fig. 5 B). Thus, we conclude that kinetochores in
MAD1 E53/56K mutant cells are compromised in their SAC
signaling due to delayed recruitment of MAD2.
MAD1 remains associated with TPR and condensing
chromosomes when it cannot bind cyclin B1
MAD2 has to bind MAD1 to be recruited to kinetochores (Chen
et al., 1998); therefore, we analyzed the behavior of MAD1 in
mutant and parental cells as they entered mitosis. We found that
like MAD2, MAD1 recruitment to kinetochores was also per-
turbed when MAD1 was unable to bind cyclin B1, and this was
because the MAD1 now appeared to remain associated with the
condensing chromosomes (Fig. 6 A). We hypothesized that this
might be caused by inefficient release from the nuclear basket;
therefore, we analyzed the behavior of the TPR protein that
binds MAD1 and is required for its localization to the NPC (Lee
et al., 2008). In agreement with our hypothesis, this revealed
Figure 2. The E53K/E56K mutation prevents MAD1 binding to cyclin B1
but not MAD2. (A) Parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells
(Par.) or clones 7D2 and 8B12 carrying a homozygous mutation of E53/E56K
in MAD1 were synchronized to enrich for G2 phase and mitosis; cyclin B1 (Cyc
B1) was immunoprecipitated, subjected to SDS-PAGE, and immunoblotted
with anti-MAD1 antibodies. (B) Parental RPE cyclin B1-Venus+/−:Ruby-
MAD2+/− cells (Par.) or clones 7D2 and 8B12 were synchronized in G2 and M
phase, and MAD1 was immunoprecipitated, and immunoblotted with anti-
MAD1 (upper panel) and anti-MAD2 (lower panel) antibodies. (C) Parental
RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells or MAD1 E53/E56K clones 7D2
and 8B12 were assayed by spinning disk confocal time-lapse microscopy.
Images of maximum intensity projections of cyclin B1-Venus (left, green),
Ruby-MAD2 (middle, red), and the merged image (right) for a representative
prometaphase cell are shown. See Videos 1, 2, and 3. Data shown for all
panels are representative of three independent experiments. Total number of
cells: parental n = 21 cells, clone 7D2 n = 16 cells, clone 8B12 n = 10 cells. Scale
bar, 3 µm.
Jackman et al. Journal of Cell Biology 5 of 17
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that mutant MAD1 that cannot bind cyclin B1 remained associ-
ated with TPR on chromosomes in early mitosis (Fig. 6 A).
We then asked whether the release of MAD1 from TPR might
also be sensitive to MPS1 kinase activity and analyzed the lo-
calization of TPR andMAD1 in cells treated with a low dose of an
MPS1 inhibitor. This had a striking effect in the MAD1 E53/56K
cells where TPR andMAD1 almost completely colocalized around
the chromosomes and very little MAD1 was able to bind to the
newly formed kinetochores. We saw a similar but milder effect
on MAD1 in the parental RPE cells (Fig. 6 B).
The effect of theMAD1mutant is partially rescued by directing
cyclin B1 to the NPC
Our results indicated that localized cyclin B1-Cdk1 synergizes
with MPS1 to release MAD1 from TPR and allow its recruitment
to kinetochores. If this was the case, then we should be able to
detect cyclin B1 colocalizing with TPR in wild-type cells, and this
should be perturbed in the MAD1 mutants. To assay this, we
fixed cells, stained them with antibodies to detect cyclin B1 and
TPR, and identified prophase cells by the extent of chromosome
condensation and the nuclear import of cyclin B1. This analysis
Figure 3. MAD1 binding to Cyclin B1 is required for genomic stability. (A) Chromosome number per cell was assayed for parental RPE yclin B1-Venus+/−:
Ruby-MAD2+/− cells and the MAD1 E53/E56K clones 7D2 and 8B12 by metaphase spreads in three independent experiments. Black dots indicate 46 chro-
mosomes and n indicates the number of cells assayed. Parental n = 89 cells, clone 7D2 n = 74 cells, clone 8B12 n = 80 cells. (B) The time from NEBD to anaphase
was measured for parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells and the MAD1 E53/E56K clones 7D2 and 8B12 by time-lapse DIC microscopy. Violin
plots show the data from three experiments (median time indicated by the black bar); n indicates the total number of cells analyzed. Parental n = 198 cells,
clone 7D2 n = 197 cells, clone 8B12 n = 201 cells. (C) The duration of the mitotic arrest for parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells and the MAD1
E53/E56K clones 7D2 and 8B12 was assayed by time-lapse DIC microscopy in 55 nM nocodazole. Data are plotted as for B; n indicates the total number of cells
analyzed. Parental n = 273 cells, clone 7D2 n = 228 cells, clone 8B12 n = 231 cells. The two-tailed P values were calculated using a Mann–Whitney unpaired
t test.
Jackman et al. Journal of Cell Biology 6 of 17




 https://rupress.org/jcb/article-pdf/219/6/e201907082/1041392/jcb_201907082.pdf by Institute For C
ancer R
esearch user on 18 M
ay 2020
showed that a proportion of cyclin B1 colocalized with TPR at the
nuclear envelope in wild-type cells (Fig. 7 A), and that this was
significantly reduced in cells with mutated MAD1 (Fig. 7 A,
quantified in Fig. 7 B). We postulated that restoring cyclin B1 to
the nuclear pore might rescue the effect of the MAD1 E53/56K
mutant on the SAC. To test this, we took the POM121 nuclear
pore protein that binds the inner nuclear membrane, and fused
an mTurquoise2 (mTurq2)-labeled GFP-binding protein nano-
body (GBP) to its C terminus. This should bind to cyclin B1-
Venus and recruit it to the NPC. We randomly integrated the
cDNA encoding this fusion protein into the RPE1 cyclin B1-
Venus:Ruby-MAD2 cell line and into MAD1 E53/56K clone 7D2
whereMAD2 was only released from the NPC at NEBD. Live-cell
imaging revealed that cells expressing the POM121-mTurq2-GBP
fusion protein recruited cyclin B1-Venus to the NPC (Fig. 7 C).
We then treated these cells with 100 nM paclitaxel plus 166 nM
reversine and assayed the ability of these cells to maintain a
mitotic arrest. We compared the behavior of these cells to cells
expressing randomly integrated POM121 fused to mTurq2 alone
and to the parental cyclin B1-Venus:Ruby-MAD2 cells expressing
either POM121 or POM121-GBP fusion proteins as controls
(Fig. 7 D). In four separate experiments, we found that cells
expressing the POM121-GBP fusion protein were able to main-
tain a mitotic arrest for more than twice as long as cells ex-
pressing POM121, and live-cell imaging showed that in 10 out of
10 of these cells, MAD2 was released from the nuclear envelope
2 to 4 min earlier than NEBD (see Videos 8 and 9). Thus, we
conclude that cyclin B1-Cdk1 at the NPC is required for the
timely release of MAD1 from the NPC, which contributes toward
the generation of a robust SAC.
Figure 4. Cells with mutant MAD1 mutant that cannot bind cyclin B1 are sensitive to partial MPS1 inhibition. (A and B) The timing from NEBD to
anaphase was measured in parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells and in the MAD1 E53/E56K clones 7D2 and 8B12 by time-lapse DIC mi-
croscopy. Cells were treated with 166 nM reversine (A) or with 55 nM nocodazole plus 166 nM reversine (B) and the data plotted as in Fig. 3. Median values are
shown as a black line, n indicates the number of cells analyzed, and the two-tailed P values were calculated using an unpaired Mann–Whitney t test. Data from
at least three independent experiments are shown. (A) Parental n = 104 cells, clone 7D2 n = 189 cells, clone 8B12 n = 107 cells. (B) Parental n = 86 cells, clone
7D2 n = 93 cells, clone 8B12 n = 79 cells. (C) Quantification of lagging chromosomes in 166 nM reversine-treated parental RPE cyclin B1-Venus+/−, Ruby-
MAD2+/− MAD1 wild type (wt) and the MAD1 E53/E56K 7D2 and 8B12 clones stained with SiR-DNA (see Videos 4 and 5). Error bars show SD. Parental n = 110
cells, clone 7D2 n = 182, clone 8D2 n = 108. (D) Cyclin B1-Venus degradation curves from parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells and from the
MAD1 E53/E56K clones 7D2 and 8B12 treated with 166 nM reversine. Cyclin B1-Venus fluorescence levels were normalized to the value at NEBD and the mean
values from >20 cells analyzed per experiment plotted, with the bars showing the SD. Data are representative of three experiments.
Jackman et al. Journal of Cell Biology 7 of 17




 https://rupress.org/jcb/article-pdf/219/6/e201907082/1041392/jcb_201907082.pdf by Institute For C
ancer R
esearch user on 18 M
ay 2020
Discussion
In this study, we have shown that cyclin B1 binds to the MAD1
protein through a predicted acidic patch on a helix of MAD1.
Unexpectedly, we find that MAD1 recruits cyclin B1-Cdk1 to
promote its own release from the NPC before NEBD, and that
cyclin B1-Cdk1 coordinates with the MPS1 kinase to achieve this.
The importance of releasing MAD1 before NEBD is that this al-
lows it to bind to kinetochores, where it can begin to generate
the MCC to inhibit the APC/C as it is activated by cyclin B1-Cdk1.
Thus, our findings identify a simple but elegant mechanism by
which the rising level of cyclin B1-Cdk1 activity before NEBD
activates the APC/C and sets up the conditions to inhibit it until
all the chromosomes attach to the mitotic spindle, thereby
contributing to genomic stability.
We identified MAD1 as the most prominent interaction
partner of cyclin B1-Cdk1. We and others (Alfonso-Pe´rez et al.,
2019) identified the N terminus of MAD1 as the binding site for
cyclin B1. It is intriguing to note that this binding site is lost in
the MAD1β spliced form that is prominent in hepatocellular
carcinoma cell lines (Sze et al., 2008); it is conceivable that the
inability to bind cyclin B1, along with the loss of the nuclear
localization signal, might contribute to their genomic instability.
We subsequently narrowed down the cyclin B1 binding motif to
a predicted acidic patch on a helical region of MAD1, a region
identified independently by Allan et al. (2020). Although beyond
the scope of our present study, we are currently determining
whether this is a conserved interaction motif for other mitotic
substrates of cyclin B1. If so, this will be, to our knowledge, the
first interaction motif specific for the major mitotic kinase in
animal cells. It is interesting to note that recognition of a helix
may be a conserved feature of the cyclins since the D-type cy-
clins recognize a predicted helix in the C terminus of retino-
blastoma protein (Topacio et al., 2019).
It is notable that preventing MAD1 from binding to cyclin B1
perturbs its release from the NPC even though there is plenty of
active cyclin B1-Cdk1 freely diffusing within the cell. It is for-
mally possible that cyclin B1 may be acting in a noncatalytic role
to promote MAD1 release, for example as a scaffold to recruit
another protein, but since both MAD1 and TPR are phosphory-
lated in mitosis on CDK consensus sites (www.phosphosite.org),
and cyclin B1-Cdk1 phosphorylates Nup98 and Nup53 to pro-
mote NPC disassembly (Linder et al., 2017), applying Occam’s
razor would argue that cyclin B1-Cdk1 activity at the NPC helps
release MAD1 from the nuclear pore. Thus, our study likely
Figure 5. MAD2 recruitment to kinetochores is delayed when MAD1 cannot bind cyclin B1. (A) Maximum intensity projections at the indicated times
from time-lapse fluorescence of parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/−:RFP670-MIS12+/+ cells and the MAD1 E53/E56K+/+: RFP670-MIS12+/+ clones
7D2 and 8B12 showing Ruby-MAD2 localization relative to NEBD. Scale bar, 5 µm. (B) Quantification of Ruby-MAD2 colocalization with RFP670-MIS12 using
the Coloc-3DT program (see Materials and methods) relative to NEBD. Graphs show values obtained from at least 40 cells for each clone in three independent
experiments. Error bars indicate SEM.
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identifies an important function for localized cyclin B1-Cdk1
activity and adds to our understanding of the increasing im-
portance of local kinase-phosphatase gradients in controlling the
cell (reviewed in Pines and Hagan, 2011). Spatial control of cyclin
B1-Cdk1 has been clearly demonstrated in triggering mitosis
from the spindle pole body in fission yeast (Grallert et al., 2013;
Hagan and Grallert, 2013), as has the spatial control of Plk1
through its recruitment to substrates previously phosphorylated
by Cdk1 (Elia et al., 2003a,b), and in the control of error cor-
rection at kinetochores through the balance of Aurora B and PP1/
Figure 6. MAD1 remains associated with TPR and condensing chromosomes when it cannot bind cyclin B1. (A) Prometaphase parental RPE cyclin B1-
Venus+/−:Ruby-MAD2+/− cells and the MAD1 E53/E56K clones 7D2 and 8B12 were fixed and stained with Hoechst 33342 (blue), anti-TPR (green), anti-MAD1
(red), and ACA antibodies as indicated. Scale bar, 2 µm. (B) Quantification of MAD1-TPR colocalization percentage shown in A (parental n = 12 cells; 7D2 n = 10
cells; 8B12 n = 10 cells). (C) Cells were fixed and stained as in A except that they were pretreated with 166 nM reversine. Scale bar, 2 µm. Images are
representative of two independent experiments. (D) Quantification of MAD1-TPR colocalization percentage shown in C (parental n = 11 cells; 7D2 n = 11 cells;
8B12 n = 9 cells).
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Figure 7. Cyclin B1 colocalizes with TPR at the nuclear membrane during mitotic entry, and targeting it to the NPC partially restores the SAC.
(A) Representative immunofluorescence images of parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/−; RFP670-MIS12+/+ and MAD1 E53/E56K 7D2 and 8B12
clones fixed and stained for TPR, cyclin B1, and DNA just before NEBD. Scale bar, 5 µm for labeled panels. Right: Merged images of TPR and cyclin B1 in the area
highlighted by the white rectangle. Scale bar, 2 µm. (B) Quantification of the colocalization between TPR and cyclin B1. Box plots show the mean and quartile
values; whiskers show the maximum and minimum values. The results are calculated from at least two independent experiments (parental RPE clone, n = 34
cells; 7D2 clone, n = 24 cells; 8B12 clone, n = 24 cells). (C) Maximum projection images of parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/−:RFP670-MIS12+/+
cells expressing either POM121-mTurq2 (top panels) or POM121-GBP-mTurq2 (bottom panels). Left: Localization of POM121-mTurq2 or POM121-GBP-mTurq2
at the NPC; middle: cyclin B1-Venus; right: the merged images. Scale bar, 5 µm. (D) The duration of mitotic arrest in 166 nM reversine + 100 nM paclitaxel for
parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells and the MAD1 E53/E56K clone 7D2 expressing POM121-mTurq2 or POM121-GBP-mTurq2 was assayed by
time-lapse microscopy and the data plotted using Prism software. The two-tailed P values were calculated using a Mann–Whitney unpaired t test. For the
POM121-GBP-mTurq2-expressing cells, only those cells where cyclin B1-Venus was clearly recruited to the nuclear envelope were analyzed. See Videos 8 and 9.
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PP2A phosphatases activities (Liu et al., 2010; Welburn et al.,
2010; reviewed in Gelens et al., 2018; Liu et al., 2010).
In addition to emphasizing the importance of spatial control
of the mitotic kinases, our study also identifies how the reor-
ganization of the interphase cell is important for the subsequent
function of mitosis-specific structures; in particular, how the
disassembly of the NPC is coordinated with assembly of a
functional kinetochore. The connection between NPC compo-
nents and the kinetochore has been known for some time: in
addition to MAD1/MAD2, the Nup107-160 complex, Nup358/
RanBP2, and Crm1 proteins all associate with the kinetochores
(Arnaoutov et al., 2005; Joseph et al., 2004; Zuccolo et al., 2007).
Our findings now show how the timing of NPC disassembly is
important for timely recruitment of MAD1 and MAD2 to
kinetochores.
Ourwork implicating the interaction between TPR andMAD1
as particularly important in the SAC is in line with some pre-
vious studies. Human TPR has been reported to bind to kine-
tochores, where it has been suggested to act as a loading factor to
recruit MAD1/MAD2 (Lee et al., 2008); however, in our studies,
we have not been able to detect TPR at kinetochores. Indeed, our
data indicate that TPR antagonizes MAD1 binding to kineto-
chores. In agreement with this, Drosophila, TPR/Megator has
been reported to strengthen the SAC but does not bind kineto-
chores (Lince-Faria et al., 2009). There is more agreement on a
role for the interaction between TPR and MAD1/MAD2 in inter-
phase cells, where in both Drosophila and human cells, TPR is
important to stabilize MAD1 and MAD2 protein levels (Schweizer
et al., 2013; Lee et al., 2008), perhaps through preventing MAD1
SUMOylation (Schweizer et al., 2013).
The role of Cdk1 in NPC disassembly has been most clearly
shown in studies using a powerful in vitro system (Linder et al.,
2017; Marino et al., 2014). These studies have implicated the Plk1
and Nek kinases working in coordination with Cdk1 to phos-
phorylate the core NPC components Nup98 and Nup53. More-
over, a recently published study revealed an important role for
the MPS1 kinase in releasing MAD1 and MAD2 from the nuclear
pores through phosphorylating TPR in Drosophila (Cunha-Silva
et al., 2020). Our study indicates that this is likely to be con-
served in evolution, and reveals that MPS1 is coordinated with
Cdk1 in freeing MAD1 from TPR at the inner-NPC “basket.”
MPS1 has also been shown to localize to the nuclear pore in
HeLa cells (Liu et al., 2003) although we have been unable to
confirm this (data not shown). It is possible that active cyclin B1-
CDK1 at the inner nuclear pore potentiates MPS1 activity (Morin
et al., 2012), exactly where it is needed to release MAD1 from the
nuclear pore. A role for MPS1 in helping the release of MAD1
from TPR can explain why it has to be inhibited beforemitosis to
prevent MAD1 localization to unattached kinetochores (Hewitt
et al., 2010), i.e., before release of MAD1 from the NPC.
It is intriguing to note that Plk1 and MPS1 recognize the same
primary consensus motif (φ-D/E-X-S; Dou et al., 2011) and that
they can cooperate by phosphorylating the same sites on pro-
teins at the kinetochore (von Schubert et al., 2015). Therefore, it
is tempting to speculate that some of the NPC components
postulated to be phosphorylated by Plk1 might also be substrates
of MPS1.
Once MAD1 has been released from TPR, it binds to unat-
tached kinetochores, where it can continue to recruit cyclin B1.
The binding of cyclin B1 to unattached kinetochores has been
observed by a number of groups (Bentley et al., 2007; Chen et al.,
2008; Alfonso-Pe´rez et al., 2019), and this “guilt by association”
is one piece of evidence implicating cyclin B1-Cdk1 in the me-
chanics of the SAC and chromosome attachment. The problem in
interpreting previous studies designed to elucidate the role of
cyclin B1-Cdk1 in the SAC is the many SAC-independent roles
that the kinase plays inmitosis: preventing cells from separating
their sister chromatids or exiting mitosis; maintaining outer
kinetochore structures; preventing the activation of Cdh1; and
repressing phosphatase activity (Holt et al., 2008; Qian et al.,
2015; Visintin et al., 1998; Zachariae et al., 1998). Additional
caveats are introduced in studies using small molecule in-
hibitors, which can affect other cyclin-Cdk family members and
related kinase families. Thus, it has been difficult to ascribe a
direct role for cyclin B1-Cdk1 in the SAC. We have overcome
these problems by identifying and characterizing a point mutant
of MAD1 that prevents cyclin B1 from being recruited to the
kinetochore but leaves the rest of the cyclin B1-Cdk1 population
active in the cell. A recent study used a large deletion mutant of
MAD1 to address the same question, but this mutant lacked 100
amino acids from the N terminus of MAD1 (Alfonso-Pe´rez et al.,
2019), thereby removing a number of other important functional
domains, including the nuclear localization signal that is re-
quired for it to bind to the NPC (our observation) and the ability
to form a stable putative coiled-coil region that may contribute
to kinetochore binding. This study concluded that by binding
cyclin B1-CDK1, MAD1 increased MPS1 recruitment to kineto-
chores. We show here that MAD1 also has to bind cyclin B1 to be
efficiently released from the NPC and properly recruited to the
kinetochore.
MAD1 binding to cyclin B1 could subsequently play a role at
unattached kinetochores later in mitosis; indeed, Allan et al.
(2020) have recently presented evidence that cyclin B1 may
form a scaffold that recruits MAD1 at the corona of prometa-
phase kinetochores to maintain the SAC. Nevertheless, our
ability to strengthen significantly the SAC in the MAD1 mutants
by ectopically targeting cyclin B1 to the NPC through POM121
shows that localized cyclin B1-Cdk1 is important for the proper
control of mitosis. This targeting experiment was not perfect,
however, since POM121 is not at the nuclear basket, and thismay
be why MAD1/MAD2 was only released 2 to 4 min before NEBD
and thus only partially rescued the SAC defect.
Finally, our study reveals a mechanism by which the cell uses
cyclin B1-Cdk1 to coordinate activation of the APC/C at NEBD
with its immediate inhibition by the MCC to ensure genomic
stability. We show here that cyclin B1-Cdk1 binding to MAD1
cooperates with MPS1 to trigger MAD1/MAD2 release and re-
cruitment to the newly formed kinetochore 10 min or more
before NEBD and APC/C activation (den Elzen and Pines, 2001;
Di Fiore and Pines, 2010; Geley et al., 2001). Thus, our results
reveal that kinetochores recruit components necessary to gen-
erate the MCC several minutes before NEBD as the APC/C is
activated (Gavet and Pines, 2010), which should be sufficient
time to generate a pool of MCC to inhibit the APC/C immediately
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upon NEBD. This model has the benefit that it simplifies the
mechanisms required to inhibit the APC/C in early mitosis since
the source of the MCC is the canonical unattached kinetochore.
Its importance is underlined by the genomic instability man-
ifested when MAD1 can no longer bind to cyclin B1.
Materials and methods
Plasmids and cell lines
MAD1 was tagged at the C terminus with a 3xHA-Flag epitope by
PCR and cloned into a modified version of pcDNA5 FRT/TO
(Thermo Fisher Scientific). Full-length MAD1 carrying either
L51G/E52A/E53A/R54A/E56 or E53Q/E56Q mutations were
tagged at the C terminus with mRuby by sub-cloning into the
pMCSV vector. The POM121 coding region was amplified by PCR
from POM121-EGFP3 plasmid (kind gift from M. Hetzer, Salk
Institute, La Jolla, CA) and tagged at the C terminus by sub-
cloning into a modified version of pMCSV containing either
mTurq2 or GBP (GFP-binding protein)-mTurq2. To generate
stable cell lines, parental RPE1 and clones 7D2 and 8B12 all
expressing cyclin B1-Venus:Ruby-MAD2:RFP670-MIS12 were
transfected with POM121-mTurq2 and POM121-GBP-mTurq2,
and cells were selected with 0.4 µg/ml neomycin (GIBCO). All
constructs were verified by sequencing, and sequences are
available on request.
Cell culture and synchronization
HeLa FRT/TO cells weremaintained in Advanced DMEM (Gibco)
supplemented with 2% FBS, GlutaMAX (Invitrogen), penicillin
(100 U/ml), streptomycin (100 µg/ml), and Fungizone (0.5 µg/
ml). RPE1 cells were cultured in F12/DMEM (Sigma-Aldrich)
medium supplemented with GlutaMAX (Invitrogen), 10% FBS
(Gibco), 0.348% sodium bicarbonate, penicillin (100 U/ml),
streptomycin (100 µg/ml), and Fungizone (0.5 µg/ml). Cells
were maintained in a 37°C incubator with 5% CO2. HeLa FRT/TO
cells were transfected using the Flp-in-System (Thermo Fisher
Scientific). Cells were induced with tetracycline (1 µg/ml; Cal-
biochem) 12 h before harvesting. HeLa FRT/TO cells were syn-
chronized in S phase by a double thymidine (2.5 mM) block,
then either released for 10 h for G2 phase arrested extracts, or
for mitotic cells, released into nocodazole (0.33 mM) for 14 h
before mitotic cells were collected by shake off. RPE1 cells were
synchronized in G2 phase through a 24-h treatment with 100
nM Palbociclib (Selleckchem) followed by 14 h release into fresh
medium.
Drug treatments
For live-cell experiments, cells were treated with 50 nM sirDNA
(Tebu-Bio) for 3 h before filming. AZ3146 (0.62 µM, Tocris),
Taxol (100 nM, Sigma-Aldrich), reversine (166 nM, Cambridge
BioScience), and nocodazole (55 nM, Sigma-Aldrich) were added
just before filming.
Genome editing
Genome editing was performed using CRISPR/Cas9D10A tech-
nology. For the MAD1 E53/56K mutation, a donor plasmid
(pJ241-305516 MAD1 E53K/E56K, synthesized by ATUM)
comprising 12 silent point mutations in addition to the E53/56K
substitutions (see Fig. S2, A and B) and flanked by 400 bp (5 )
and 800 bp (3 ) sequences, was linearized through NotI di-
gestion. The linearized plasmid was purified (GeneJET Gel
Extraction Kit, Thermo Fisher Scientific), and cotransfected
into RPE1 cyclin B1-Venus:Ruby-MAD2 (Collin et al., 2013) to-
gether with a modified version of the PX466 “All-in-One”
plasmid (Chiang et al., 2016) containing Cas9D10A-T2A-RFP670
and gRNAs targeting MAD1 exon4 (5 -TCACTGAGGATTCTG
TTTTT-3 and 5 -GGTGCGACCTGCTCAGCTGG-3 ). RFP670-
expressing cells were selected using a FACSAria III (BD Bio-
sciences) and sorted individually into a 96-well plate. For
genotyping, genomic DNA was prepared using DirectCell-PCR
Lysis-Reagent Cell (VWR) according to the manufacturer’s
protocol and screened by PCR using a FailSafe PCR kit (Buffer E,
Epicentre). The presence of MAD1 E53/56K substitutions was
identified through PCR using forward primers annealing to the
mutated or the wild-type sequences (5 -AGCTGGAAAAGAGGG
CGAAAC-3 and 5 -TAAGTGCCGGGAGATGCTG-3 , respectively)
and the same reverse primer (5 -AGCCCACACAACGCACAC
CGA-3 ). Positive clones for the E53/56K mutations were
screened using primers annealing ∼200 bp upstream and
downstream of the point mutations. PCR products were sepa-
rated on agarose gels, cloned into the pDrive vector (Qiagen),
and sequenced as shown in Fig. S2. The MIS12 locus was tar-
geted with RFP670 as shown in Fig. S4. A donor plasmid con-
taining RFP670 sequence in frame with MIS12 exon1 flanked by
homology regions was cotransfected with the “All-in-One”
plasmid comprising MIS12 specific gRNAs (5 -ATGACCTAC
GAGGCCCAGTT-3 and 5 -CGCCACAAACGTGCATGCTT-3 )
and Cas9D10A-T2A-EGFP. EGFP-positive cells were selected via
FACS then sorted individually by FACS 10 d later. RFP670
positive clones were identified by PCR (as shown in Fig. S4 B)
and subsequently analyzed by live-cell microscopy to confirm
MIS12 expression and localization (Fig. S4 C).
Metaphase spreads
Cells were treated with 0.1 µg/ml colcemid (GIBCO) for 3 h,
trypsinized, washed twice with 1× PBS, and resuspended in
hypotonic buffer (0.075 M KCl). After a 20 min incubation at
37°C, cells were centrifuged, and the pellet was gently re-
suspended in 3:1 methanol/glacial acetic acid fixative (vortex
dropwise). Cells were washed with fixative three times, and a
few drops were released onto an alcohol-cleaned slide and al-
lowed to air-dry. Slides were counterstained with KaryoMAX
Giemsa Stain Solution (GIBCO). Transmitted light images of
metaphase spreads were captured using a 63× 1.4 NA lens, and
the number of chromosomes per cell was counted using ImageJ
software.
Immunoprecipitation
Cells were lysed in lysis buffer (0.5% NP-40 wt/vol, 140 mM
NaCl, 10 mM KCl, 50 mM Hepes, pH 7.2, 10% wt/vol glycerol,
1 mM EDTA, and HALT protease inhibitor cocktail; Thermo
Fisher Scientific). Supernatants from 11,000 xg centrifugation of
cell lysates were incubated with anti-Cyclin B1 (GNS1, Phar-
Mingen) or anti-MAD1 (9B10, Sigma-Aldrich) antibodies
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coupled to Protein G-Dynabeads (Thermo Fisher Scientific) for
1 h at 4°C, washed four times in lysis buffer, and eluted at 65°C
for 5 min before analysis by SDS-PAGE and silver or Colloidal
Blue staining, or immunoblotting. Silver staining was performed
according to manufacturers’ instructions (SilverQuest, Sigma-
Aldrich). For Colloidal Blue staining, the gel was fixed in 40%
methanol and 2% acetic acid for 30 min, then stained with
Brilliant Blue G solution (Sigma-Aldrich), prepared overnight as
per the manufacturer’s instructions, then destained with 30%
methanol until the background was clear.
Mass spectrometry (MS)
For MS analyses, immunoprecipitates on Protein-G Dynabeads
(Thermo Fisher Scientific) were washed 2× with triethy-
lammonium bicarbonate buffer (100 mM) and incubated with
trypsin (Roche) at 37°C for 18 h. The tryptic peptides were col-
lected and tandem mass tag (TMT)-labeled according to manu-
facturers’ instructions (ThermoFisher Scientific). The TMT
peptides were fractionated on a U3000 HPLC system (Thermo
Fisher Scientific) using an XBridge BEH C18 column (2.1 mm
internal diameter [i.d.] × 15 cm, 130 A˚, 3.5 µm; Waters) at pH 10,
with a 30-min linear gradient from 5–35% acetonitrile/NH4OH
at a flow rate at 200 µl/min. The fractions were collected every
30 s into a 96-well plate by rows, then concatenated by columns
to 12 pooled fractions and dried in a SpeedVac. The peptides
were redissolved in 0.5% formic acid (FA) before liquid chro-
motography tandem mass spectrometry (LC-MS/MS) analysis.
The LC-MS/MS analysis were performed on the Orbitrap Fusion
Lumos mass spectrometer coupled with U3000 RSLCnano
UHPLC system (Thermo Fisher Scientific). The peptides were
first loaded to a PepMap C18 trap (100 µm i.d. x 20 mm, 100 A˚,
5 µm) for 8 min at 10 µl/min with 0.1% FA/H2O, then separated
on a PepMap C18 column (75 µm i.d. × 500 mm, 100 A˚, 2 µm) at
300 nl/min and a linear gradient of 8–30.4% acetonitrile/0.1%
FA in 120 min/cycle at 150 min for each fraction. The data ac-
quisition used the SPS5-MS3 method with Top Speed at 3 s per
cycle time. The full MS scans (m/z 375–1500) were acquired at
120,000 resolution at m/z 200, and the automatic gain control
(AGC) was set at 4x105 with 50msmaximum injection time. The
most abundant multiply-charge ions (z = 2–5, above 10,000
counts) were subjected to MS/MS fragmentation by collision-
induced dissociation (35% collision energy) and detected in an ion
trap for peptide identification. The isolation window by quadru-
pole was set m/z 0.7, and AGC at 10,000 with 50 ms maximum
injection time. The dynamic exclusion window was set ±7 ppm
with a duration at 40 s, and only single charge status per precursor
was fragmented. Following each MS/MS, the five-notch MS/MS/
MS (fragment MS) was performed on the top five most abundant
fragments isolated by synchronous precursor selection. The pre-
cursors were fragmented by higher-energy collisional dissociation
at 65% CE, then detected in Orbitrap at m/z 100–500 with 50,000
resolution for peptide quantification data. The AGC was set at
100,000 with maximum injection time at 105 ms.
Data analysis
The LC-MS/MS data were processed in Proteome Discoverer 2.2
(Thermo Fisher Scientific) using SequestHT and Mascot search
engines against the SwissProt protein database (v. August 2018)
plus the cRAP contaminant database (ftp://ftp.thegpm.org/
fasta/cRAP). The precursor mass tolerance was set at 15 ppm,
and the fragment ion mass tolerance was set at 0.5 D. Spectra
were searched for fully tryptic peptides with maximum of two
miscleavages. TMT6plex (peptide N terminus, K) was set as
static modification, and dynamic modifications included deam-
idation (N, Q), oxidation (M), and phosphorylation (S, T, Y).
Peptides were validated by Percolator with q value threshold set
at 0.05 for the decoy database search. Phosphorylation site lo-
cations were verified by the ptmRS module. The search result
was filtered to achieve a protein false discovery rate of 0.05. The
TMT10plex reporter ion quantifier used 20 ppm integration
tolerance on the most confident centroid peak at the MS3 level.
Only unique peptides were used for quantification. The co-
isolation threshold was set to 100%. Peptides with average re-
ported S/n >3 were used for protein quantification. Only master
proteins were reported. Only proteinswith quantification values
in all samples were used for further analyses. Protein abun-
dances were normalized to the bait protein in each immuno-
precipitation subset. To filter out nonspecific proteins, a Linear
Models for Microarray–based differential analysis was per-
formed comparing MAD1 immunoprecipitations among them-
selves or versus IgG control samples. Proteins were deemed
significantly different if adjusted P < 0.05 and twofold difference
in abundance.
Immunoblotting
For immunoblot analyses, cell lysates were loaded and run on
a 4–12% NuPAGE gel (Invitrogen) and transferred to an
Immobilon-FL polyvinylidene fluoride membrane (IPFL00010,
Millipore) before immunoblotting (Di Fiore and Pines, 2010).
Primary antibodies were used at the indicated concentrations:
anti-MAD1 (clone 9B10, 1:400, mouse, Sigma-Aldrich, 2 mg/ml),
anti-Flag (M2, F3165, 1:4,000, mouse, Sigma-Aldrich), anti-Mad2
(A300-301A; 1:1,000, rabbit, Bethyl Laboratories), and anti-
cyclin B1 (GNSI, 1:500, PharMingen). IRDye800CW donkey
anti-mouse (926–32212, LI-COR), IRDye800CW donkey anti-
rabbit (926–32213, LI-COR), IRDye680CW donkey anti-mouse
(926–68072, LI-COR), and IRDye680CW donkey anti-rabbit
(926–68073, LI-COR) secondary antibodies were all used at 1:
10,000. Quantitative immunoblotting was performed on a LI-
COR Odyssey CLx scanner according to the manufacturer’s in-
structions (LI-COR Biosciences).
Immunofluorescence
To costain forMAD1 and TPR, cells were fixed for 15min at room
temperature in 60mMPipes, 25mMHepes, 10mMEGTA, 2mM
MgCl2, pH 6.9, buffered with KOH) buffer with 4% wt/vol par-
aformaldehyde and 0.5% vol/vol Triton X-100 . Primary anti-
bodies were diluted as follows: TPR (HPA024336, rabbit, Atlas
antibodies) 1:50; MAD1 (9B10, Sigma-Aldrich, 2 mg/ml) 1:200
and human anti--centromere autoantibody (ACA) (CS1058, hu-
man, Cortex Biochem) 1:200. To costain for cyclin B1 and TPR,
cells were fixed for 2 min in 50%methanol and 50% acetone and
washed with PBS. Primary antibodies were diluted as follows:
anti-cyclin B1 (GNSI, PharMingen) 1:100, and anti-TPR as above.
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Secondary antibodies were anti-mouse-594 nm, anti-rabbit-488
nm, and anti-human-647 nm (Alexa Fluor, Thermo Fisher Sci-
entific), all at 1:400. Confocal imaging of antibody-stained
samples was performed on a Marianas microscope (Intelligent
Imaging Innovations).
Colocalization analysis
To measure the colocalization of TPR and MAD1 a 4.2 µm2
representative region of interest (ROI) was defined from the
maximum projection image of each cell. The percentage TPR and
MAD1 colocalization was calculated with the Fiji plugin “Coloc-
alization Threshold” (National Institutes of Health, public do-
main; colocalization threshold plug-in: authors Tony Collins and
Wayne Rasband).
To measure the colocalization of TPR and cyclin B1 at the
nuclear membrane, cells were costained with anti-TPR and anti-
cyclin B1 antibodies and visualized using a Super-resolution via
optical reassignment (SoRa) Spinning Disc microscope (Intelli-
gent Imaging Innovations and Yokogawa). Late prophase cells
just before NEBD were identified by the localization of cyclin B1
and the extent of chromosome condensation. From each confocal
Z-section image taken through the center of each cell, a repre-
sentative 6-µm-long ROI of TPR signal at the nuclear membrane
was manually defined. Distribution profiles of the immunoflu-
orescence intensities of TPR and cyclin B1 along each ROI were
measured with Fiji software. The percentage of TPR and cyclin
B1 colocalization was calculated as the area of the TPR immu-
nofluorescence intensity profile that overlapped with that of
cyclin B1 (OriginLab2020).
Time-lapse imaging and analysis
For time-lapse microscopy, cells were seeded and transfected on
an eight-well chamber slide (μslide, Ibidi). Cells were pretreated
with 50 nM Sir-DNA (Spirochrome) 3 h before filming to visu-
alize chromosomes. Cells were imaged in Leibovitz’s L-15 me-
dium (GIBCO) supplemented with 10% FBS. Time-lapse confocal
imaging was performed on a Marianas confocal spinning-disk
microscope system (Intelligent Imaging Innovations, Inc.)
comprising a laser stack for 445 nm/488 nm/514 nm/561 nm
lasers; an Observer Z1 invertedmicroscope (Carl Zeiss) equipped
with Plan-Apochromat 40× 1.3 NA and 63× 1.4 NA lenses; an
OKO stage top incubator set to 37°C (OKO); a CSU X1 spinning
disk head (Yokogawa); a Gemini W view optical splitter attached
to a Flash4 CMOS camera (Hamamatsu), and a QuantEM 512SC
camera (Photometrics). The microscope was equipped with
Brightline filters (Semrock) for GFP/RFP, for CFP/YFP/RFP, and
for RFP670. Immunofluorescence images were captured on a
similar Marianas confocal microscope but equipped with a CSU
W1 head. Colocalization of Ruby-MAD2 with RFP670-MIS12 and
immunofluorescence images were collected using a 63× 1.2 NA
objective (Carl Zeiss). Time-lapse widefield fluorescence and
differential interference contrast (DIC) imaging were performed
on a Nikon Eclipse microscope (Nikon) equipped with 20× 0.75
NA, 40× 1.3 NA, and 63× 1.4 NA lenses, a Flash 4.0 CMOS camera
(Hamamatsu), an excitation and an emission filter wheel
equipped with Brightline (Semrock) filters for CFP, GFP, YFP,
RFP, and RFP670, and an analyzer in the emission wheel for DIC
imaging. Image acquisition and processing for the confocal mi-
croscopes was performed using Slidebook 6 (Intelligent Imaging
Innovation, Inc.) software; Micromanager software and ImageJ
open source software were used for widefield imaging.
3D videos of Ruby-MAD2 localization with RFP670-MIS12 of
single cells were quantified using an open source program
(https://github.com/adamltyson/coloc-3DT). Images were con-
verted to Open Microscopy Environment-Tagged Image File
Format (OME-TIFF), loaded into a custom python program, re-
sliced in Z to isotropic sampling, and smoothed with a Gaussian
filter (sigma = 1 voxel). To segment the kinetochores, the
RFP670-MIS12 signal was thresholded using an adaptation of
Otsu’s method (Otsu, 1979) in which the threshold was scaled by
a fixed value (1.08) for all experiments. Noise was removed by
morphological opening (kernel = 1 voxel cube), and then the
mean value (colocalization) of MAD2-Ruby was calculated
within the thresholded kinetochores. This colocalization was
scaled to the level of Ruby-MAD2 within the rest of the nucleus
(estimated as between 1 and 15 voxels from the segmented ki-
netochore). All image processing was performed with Scikit-
image (van der Walt et al., 2014).
Statistics
Statistical analyses were performed using GraphPad Prism.
Significance of data derived from mitotic timings was deter-
mined using unpaired Mann–Whitney tests. Statistical analyses
of MS were performed using the R package LIMMA, and pro-
teins with a logFC >2-fold and adjusted P value <0.05 were
considered significant. Binding to cyclin B1 was analyzed by
unpaired Student’s t tests. All P values are two-tailed. Data
distribution was assumed to be normal, but this was not for-
mally tested.
Online supplemental material
Fig. S1 provides supporting evidence that cyclin B1 binds to a
helical surface on MAD1. Fig. S2 shows the design of the guide
RNAs to mutate MAD1 and the genomic sequence of the mutated
MAD1 clones. Fig. S3 shows the mitotic delay of the MAD1 wild-
type and mutant clones induced by Taxol treatment. Fig. S4
shows the effect of the AZ3146 MPS1 inhibitor on the timing
of NEBD to anaphase in parental and MAD1 mutant clones. Fig.
S5 shows evidence supporting the targeting of RFP670 into the
Mis12 locus to label kinetochores. Videos 1, 2, and 3 are time-
lapse videos of fluorescently tagged cyclin B1 and MAD2 as wild-
type (Video 1) and two MAD1 E53/56K mutant clones (Videos
2 and 3) enter mitosis. Videos 4, 5, 6, and 7 are time-lapse videos
showing the kinetochore recruitment of cyclin B1 and MAD2 in
parental (Videos 4 and 6) and a MAD1 E53/56K mutant clone
(Videos 5 and 7) upon treatment with an MPS1 inhibitor. Videos
8 and 9 show the kinetochore recruitment of MAD2 in parental
(Video 8) and a MAD1 E53/56K mutant clone (Video 9) when
cyclin B1 is recruited to the NPC by Pom121.
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Figure S1. Cyclin B1 binds to MAD1 through the acidic face of a helix encoded by exon 4. Related to Fig. 1. (A) Colloidal blue stained SDS-PAGE gel of
cyclin B1 immunoprecipitated from HeLa cells. Marked bands were excised and identified by mass spectrometry. (B) Silver-stained SDS-PAGE gel of cyclin B1
immunoprecipitates from RPE cyclin B1-Venus+/−: Ruby-MAD2+/− cells (lane 1) and MAD1 E53K/E56K clone 7D2 (lane 2). (C) Cyclin B1 immunoprecipitates from
HeLa cells expressing Flag-epitope tagged MAD1α or MAD1β or MAD1 with a mutated nuclear localisation sequence KKR79-82AAA (Mad1-NLS), probed with
anti-FLAG (upper panel) or anti-cyclin B1 (lower panel) antibodies. (D) Heptad registration of acidic residues of MAD1within coiled-coil configuration, predicted
using PairCoil2. (E) Confocal image of HeLa cyclin B1-Venus+/− (green) cells transfected with either MAD1 L51G/E52A/E53A/R54A/E56A-Ruby (left panel, red)
or MAD1 E53/56K-Ruby (right panel, red). Scale bar, 10 µm.
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Figure S2. MAD1 recruits cyclin B1 to kinetochores. Related to Fig. 2. (A) Schematic showing guide RNA (gRNA, red) selection and protospacer adjacent
motif (blue) for CRISPR-Cas9D10A targeting of MAD1 exon4. (B) Genomic DNA sequencing of RPE cyclin B1-Venus+/−:MAD2-Ruby+/− MAD1 E53/56K clones 7D2
and 8B12.
Figure S3. MAD1 binding to cyclin B1 is required for genomic stability. Related to Fig. 3. The duration of the mitotic arrest for parental RPE cyclin B1-
Venus+/−:Ruby-MAD2+/− cells and the MAD1 E53/E56K clones 7D2 and 8B12 was assayed by time-lapse DIC microscopy in 100 nM paclitaxel and plotted as
black dots. The times in mitosis of cells that remained arrested for the duration of the experiment are shown separately as red dots. Total number of cells for
each clone analyzed; parental n = 187 cells, clone 7D2 n = 201 cells, clone 8B12 n = 182 cells.
Jackman et al. Journal of Cell Biology S3
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Figure S4. Cells with MAD1 mutants that cannot bind cyclin B1 are sensitive to partial inhibition of MPS1. Related to Fig. 4. (A) Time from NEBD-
anaphase for parental RPE cyclin B1-Venus+/−:MAD2-Ruby+/− cells and MAD1 E53/56K clones 7D2 and 8B12 treated with 0.62 µM AZ3146 MPS1 kinase
inhibitor. Scatter dot pots show the median (gray line) from two independent experiments (parental n = 112 cells, 7D2 n = 111 cells, 8B12 n = 117 cells). The two-
way P values were calculated using a Mann–Whitney unpaired t test.
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Video 1. Mitotic entry of parental RPE cyclin B1-Venus+/−:MAD2-Ruby+/− cell. Cyclin B1-Venus (left panel), Ruby-MAD2 (middle panel), and merged
channels cyclin B1-Venus (green) and Ruby-MAD2 (red; right panel). Cells imaged by spinning disk confocal microscopy. Frame rate, one image every 2 min.
Video 2. Mitotic entry of MAD1 E53/E56K clone 7D2. Cyclin B1-Venus (left panel), Ruby-MAD2 (middle panel), and merged channels cyclin B1-Venus
(green) and Ruby-MAD2 (red; right panel). Cells imaged by spinning disk confocal microscopy. Frame rate, one image every 2 min.
Figure S5. MAD2 recruitment to kinetochores is delayed when MAD1 cannot bind cyclin B1. Related to Fig. 5. (A) Schematic showing how RFP670 was
tagged at the N terminus of MIS12 (RHA and LHA refer to right and left homology arms, respectively). (B) PCR of genomic DNA from wild-type RPE1 cells
(control), parental RPE cyclin B1-Venus+/−: Ruby-MAD2+/−; RFP670-MIS12+/+ cells (Par.), or MAD1 E53/E56K: RFP670-MIS12+/+ clones 7D2 and 8B12, showing
integration of RFP670 into both alleles of MIS12. (C) Maximum projection images of parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/−; RFP670-MIS12+/+cells
(Par.) and MAD1 E53/E56K: RFP670-MIS12+/+ clones 7D2 and 8B12. Left panels show Ruby-MAD2; right panels show RFP670-MIS12. Scale bar, top right panel,
5 µm.
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Video 3. Mitotic entry of MAD1 E53/E56K clone 8B12. Cyclin B1-Venus (left panel), Ruby-MAD2 (middle panel), and merged channels cyclin B1-Venus
(green) and Ruby-MAD2 (red; right panel). Cells imaged by spinning disk confocal microscopy. Frame rate, one image every 2 min.
Video 4. Widefield epifluorescence video shows mitotic entry of parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/− cells treated with SiR-DNA 3 h
before filming and reversine (166 nM) just before imaging. Frame rate, one image every 2 min.
Video 5. Widefield epifluorescence video showsmitotic entry of RPE Cyclin B1-Venus+/−:Ruby-MAD2+/−MAD1E53/E56K clone 8B12 treated with SiR-
DNA 3 h before filming and reversine (166 nM) just before imaging. Frame rate, one image every 2 min.
Video 6. Spinning disk confocal video showsmitotic entry of parental RPE cyclin B1-Venus+/−:Ruby-MAD2+/−; RFP670-MIS12+/+ cells. Cyclin B1-Venus
(far left panel), Ruby-MAD2 (left panel, green), RFP670-MIS12 (right panel, red), and merged channels for MAD2 and MIS12 (far right panel). Cells treated with
reversine (166 nM) just before imaging. Note that reversine reduces the loading of cyclin B1 onto kinetochores in the parental cells. Frame rate, one image
every 2 min.
Video 7. Spinning disk confocal video shows mitotic entry of MAD1 E53/E56K clones 7D2. Cyclin B1-Venus (far left panel), Ruby-MAD2 (left panel,
green), RFP670-MIS12 (right panel, red), and merged channels for MAD2 and MIS12 (far right panel). Cells treated with reversine (166 nM) just before imaging.
Frame rate, one image every 2 min.
Video 8. Projected Z-series stacks of cells filmed using confocal spin disk microscopy with 2-min time frame. Parental RPE cyclin B1-Venus+/−:Ruby-
MAD2+/−:RFP670-MIS12+/+ expressing POM121-GBP-mTurq2. Panels, left to right, show cyclin B1-YFP, Mad2-Ruby, RFP670-Mis12, and then merged image.
Merged image Mad2-Ruby (green), RFP670-Mis12 (red).
Video 9. Projected Z-series stacks of cells filmed using confocal spin disk microscopy with 2-min time frame. MAD1 E53/E56K clone 7D2 expressing
POM121-GBP-mTurq2. Panels, left to right, show cyclin B1-YFP, Mad2-Ruby, RFP670-Mis12, and then merged image. Merged image Mad2-Ruby (green),
RFP670-Mis12 (red).
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